laidlomycin butyrate(78734-45-9)
- Name: laidlomycin butyrate
- Synonyms:1,6-Dioxaspiro[4.5]decane,monensin deriv.; Laidlomycin butyrate
- Molecular Formula:C41H68 O13
- Molecular Weight:754.9873
- CAS Registry Number:78734-45-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.78734-45-9 laidlomycin butyrate
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.78734-45-9 laidlomycin butyrate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.78734-45-9 laidlomycin butyrate
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:laidlomycin butyrate
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 100298-75-7/Coconut oil, Me ester,glycerol-free
- 159934-20-0/2H-1-Benzopyran-3,7-diol,3,4-dihydro-2,2-dimethyl-6-[(2E)-3-phenyl-2-propen-1-yl]-
- 96690-79-8/Zirconium, acetate Bu alc. C16-18-fatty acid Et acetoacetate complexes
- 6292-97-3/1-[(2-aminoethyl)sulfanyl]propan-2-ol
- 126347-60-2/D-Glucose, cyclic 4®2':6®2-[(1S)-4-(6-carboxy-2,3,4-trihydroxyphenoxy)-4',5,5',6,6'-pentahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]3-(3,4,5-trihydroxybenzoate), cyclic diester with b-D-glucopyranose cyclic 4®2:6®2'-[(1S)-4-(6-carboxy-2,3,4-trihydroxyphenoxy)-4',5,5',6,6'-pentahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]2,3-bis(3,4,5-trihydroxybenzoate) (9CI)
- 65872-84-6/N-[2-(fluoromethyl)-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-6-yl]pentanamide
- 50302-24-4/9,17-Octadecadiene-12,14-diynoic acid,16-hydroxy-,(9Z,16R)-
- 400-52-2/T-BUTYL TRIFLUOROACETATE
- 173284-28-1/4,6-dimethyl-2-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}[1,2]thiazolo[5,4-b]pyridin-3(2H)-one 1,1-dioxide
- 22261-45-6/N-[2-(1H-benzimidazol-1-yl)ethyl]-2-hydroxy-2,2-diphenylacetamide hydrochloride (1:1)
- 85022-63-5/Shikonofuran D
- 61129-19-9/4-amino-2-(methylsulfanyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-5-carboxamide
- 21528-11-0/N-(2-aminoethyl)-3-hydroxynaphthalene-2-carboxamide hydrochloride
- 87236-17-7/1-ethylchromeno[3,4-d]imidazol-4(1H)-one
- 14293-88-0/Silicic acid (H4SiO4),tetrapotassium salt (8CI,9CI)
- 7390-30-9/5-Amino-s-triazolo[1,5-a]-s-triazin-7(1H)-one
- 6556-42-9/(2E)-3-cyclohex-3-en-1-ylprop-2-enal
- 117527-84-1/16,25-Cyclocholestane(9CI)
- 175457-26-8/6-fluoro-1-(3-morpholin-4-ylphenyl)-4-oxo-7-(4-pyridin-2-ylpiperazin-1-yl)-1,8-naphthyridine-3-carboxylic acid
- 78734-45-9/laidlomycin butyrate
- 11000-04-7/Colicin
- 29339-45-5/5,5-dimethyl-3-(4-nitrophenyl)cyclohex-2-en-1-one
- 74209-44-2/2,2-Diethoxy-2-(4-pyridyl)ethylamine
- 94022-23-8/2,6-dicyclopentyl-5-isopropyl-m-cresol
- 27244-17-3/4-[(E)-{[4-(2-benzyl-1,3-thiazol-4-yl)-3-chlorophenyl]imino}methyl]-N,N-bis(2-chloroethyl)-3-methylaniline
- 140669-88-1/Bicyclo[3.2.1]oct-3-en-2-one,8-(acetyloxy)-7-(3,4-dimethoxyphenyl)-3-methoxy-6-methyl-5-(2-propen-1-yl)-,(1S,5S,6R,7R,8R)-
- 52196-11-9/SMIPINE
- 7477-24-9/2-(diethylamino)ethyl 3-(cyclohex-3-en-1-yl)-3-hydroxy-2-phenylpropanoate
- 175448-12-1/Cochleamycin B 2
- 107719-49-3/Acetic acid ethenyl ester,polymers,polymer with ethene and ethenyltrimethoxysilane,graft